Gerry Rhodes

机构：Gilead Sciences (United States)

发表论文 29 篇 · 总被引 1436 次 · h-index 14

代表论文

• An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge (2005 · Journal of Virology · 被引 463)
• Mechanism of Active Renal Tubular Efflux of Tenofovir (2006 · Antimicrobial Agents and Chemotherapy · 被引 325)
• Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer (2010 · ACS Medicinal Chemistry Letters · 被引 200)
• N -(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1 H )-yl)carboxamides:  Identification of Novel Orthopoxvirus Egress Inhibitors (2007 · Journal of Medicinal Chemistry · 被引 67)
• Nucleotide Analogue Prodrug Tenofovir Disoproxil Enhances Lymphoid Cell Loading following Oral Administration in Monkeys (2009 · Molecular Pharmaceutics · 被引 58)
• Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Na i), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties (2016 · Journal of Medicinal Chemistry · 被引 36)